- Home
- VXRT vs MIST Comparison
VXRT vs MIST Comparison
Compare VXRT & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VXRT
- MIST
- Stock Information
- Founded
- VXRT N/A
- MIST 2003
- Country
- VXRT United States
- MIST Canada
- Employees
- VXRT N/A
- MIST N/A
- Industry
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- VXRT Health Care
- MIST Health Care
- Exchange
- VXRT Nasdaq
- MIST Nasdaq
- Market Cap
- VXRT 119.0M
- MIST N/A
- IPO Year
- VXRT N/A
- MIST N/A
- Fundamental
- Price
- VXRT $0.41
- MIST $0.80
- Analyst Decision
- VXRT Strong Buy
- MIST Strong Buy
- Analyst Count
- VXRT 2
- MIST 2
- Target Price
- VXRT $3.00
- MIST $17.00
- AVG Volume (30 Days)
- VXRT 1.7M
- MIST 4.7M
- Earning Date
- VXRT 03-20-2025
- MIST 03-13-2025
- Dividend Yield
- VXRT N/A
- MIST N/A
- EPS Growth
- VXRT N/A
- MIST N/A
- EPS
- VXRT N/A
- MIST N/A
- Revenue
- VXRT $28,700,000.00
- MIST N/A
- Revenue This Year
- VXRT N/A
- MIST N/A
- Revenue Next Year
- VXRT $48.02
- MIST $1,105.43
- P/E Ratio
- VXRT N/A
- MIST N/A
- Revenue Growth
- VXRT 288.94
- MIST N/A
- 52 Week Low
- VXRT $0.39
- MIST $0.75
- 52 Week High
- VXRT $1.34
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- VXRT 30.14
- MIST 29.72
- Support Level
- VXRT $0.49
- MIST $0.75
- Resistance Level
- VXRT $0.60
- MIST $2.36
- Average True Range (ATR)
- VXRT 0.05
- MIST 0.25
- MACD
- VXRT -0.01
- MIST -0.11
- Stochastic Oscillator
- VXRT 9.77
- MIST 2.89
Stock Price Comparison Chart: VXRT vs MIST
■ VXRT
■ MIST
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Share on Social Networks:
0